UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 41

Sortiert nach

Pericarditis and myocardial infarctions after Hodgkin's disease therapy

International journal of radiation oncology, biology, physics, 1991-07, Vol.21 (2), p.447-449

1991

Link zum Volltext

Verfügbarkeit prüfen

Results of a randomized clinical trial comparing two radiation schedules in the palliative treatment of brain metastases

Radiotherapy and oncology, 1993-02, Vol.26 (2), p.111-116

1993

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant combination of carboplatin and 5-FU in head and neck cancer: A randomized study

Annals of oncology, 1992-08, Vol.3 (suppl-3), p.S43-S46

1992

Link zum Volltext

Verfügbarkeit prüfen

Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results

Seminars in oncology, 1995-12, Vol.22 (6 Suppl 15), p.29

1995

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant chemotherapy with carboplatin/5-fluorouracil in head and neck cancer

Oncology, 1993-11, Vol.50 Suppl 2, p.23

1993

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of paclitaxel and epirubicin in patients with metastatic breast cancer: a preliminary report on safety

Seminars in oncology, 1996-02, Vol.23 (1 Suppl 1), p.24

1996

Link zum Volltext

Verfügbarkeit prüfen

Local relapse and contralateral tumor rates in patients with breast cancer treated with conservative surgery and radiotherapy (institut gustave roussy 1970–1982)

Cancer, 1995-12, Vol.76 (11), p.2260-2265

1995

Link zum Volltext

Verfügbarkeit prüfen

Alternating radiotherapy and chemotherapy in 173 consecutive patients with limited small cell lung carcinoma

International journal of radiation oncology, biology, physics, 1990-11, Vol.19 (5), p.1135-1138

1990

Link zum Volltext

Verfügbarkeit prüfen

Alternating radiotherapy and chemotherapy schedules in limited small cell lung cancer: analysis of local chest recurrences

Radiotherapy and oncology, 1991-02, Vol.20 (2), p.91-98

1991

Link zum Volltext

Verfügbarkeit prüfen

Optimisation de l'association radiothérapie et chimiothérapie dans les carcinomes bronchiques non à petites cellules

Cancer radiothérapie, 1997, Vol.1 (2), p.148-153

1997

Link zum Volltext

Verfügbarkeit prüfen

Risk of secondary acute leukemia and preleukemia after Hodgkin's disease: the Institut Gustave-Roussy experience

Recent results in cancer research, 1989, Vol.117, p.270

1989

Link zum Volltext

Verfügbarkeit prüfen

A phase II trial of radiochemotherapy with daily carboplatin, after induction chemotherapy (carboplatin and etoposide), in locally advanced nonsmall-cell lung cancer: Final analysis

International journal of radiation oncology, biology, physics, 1997-04, Vol.38 (1), p.163-168

1997

Link zum Volltext

Verfügbarkeit prüfen

Alternating radiotherapy and chemotherapy in limited disease small cell lung cancer

Radiotherapy and oncology, 1998-03, Vol.46 (3), p.257-261

1998

Link zum Volltext

Verfügbarkeit prüfen

202 Phase I study of paclitaxel (P) over 1 hr infusion in combination with vinorelbine (V) in advanced non small cell lung cancer (NSCLC)

Lung cancer (Amsterdam, Netherlands), 1997-08, Vol.18, p.53-53

1997

Link zum Volltext

Verfügbarkeit prüfen

370 Taxol® (paclitaxel) and farmorubicin® (epirubicin) in metastatic breast cancer (MBC): Preliminary results of a phase I study

European journal of cancer (1990), 1995-11, Vol.31, p.S80-S81

1995

Link zum Volltext

Verfügbarkeit prüfen

128 Preliminary results of a phase II study with Taxol ® (paclitaxel) and cisplatin in advanced non-small cell lung cancer (NSCLC)

Lung cancer (Amsterdam, Netherlands), 1997-08, Vol.18, p.35-36

1997

Link zum Volltext

Verfügbarkeit prüfen

352 Induction chemotherapy (ICT cisplatin and vinorelbine) followed by a combination of daily irradiation and carboplatine (CBDCA) in stage IIIB non small cell lung cancer (NSCLC): Final analysis of a phase II trial

Lung cancer (Amsterdam, Netherlands), 1997-08, Vol.18, p.90-90

1997

Link zum Volltext

Verfügbarkeit prüfen

Phase I studies of combined paclitaxel/epirubicin and paclitaxel/epirubicin/cyclophosphamide in patients with metastatic offast cancer: the French experience

Seminars in oncology, 1997-02, Vol.24 (1 Suppl 3), p.S8

1997

Link zum Volltext

Verfügbarkeit prüfen

2139 Chemotherapy followed by a combination of daily irradiation and carboplatine (CBDCA) in stage IIIB non small cell lung cancer (NSCLC): First interim analysis of a phase II trial

International journal of radiation oncology, biology, physics, 1996, Vol.36 (1), p.345-346

1996

Link zum Volltext

Verfügbarkeit prüfen

Local relapse and contralateral tumor rates in patients with breast cancer treated with conservative surgery and radiotherapy (Institut Gustave Roussy 1970-1982). IGR Breast Cancer Group

Cancer, 1995-12, Vol.76 (11), p.2260-2265

1995

Link zum Volltext

Verfügbarkeit prüfen

354 Efficacy of induction chemotherapy (ICT) before concomitant chemoradiotherapy (CRCT) is predictive of local control and survival in unresectable locally advanced non small cell lung cancer (NSCLC)

Lung cancer (Amsterdam, Netherlands), 1997-08, Vol.18, p.91-91

1997

Link zum Volltext

Verfügbarkeit prüfen

Phase I/II study of paclitaxel plus ciplatin as first-line chemotherapy for advanced non-small cell lung cancer : Preliminary results: Emerging strategies in medical oncology

Seminars in oncology, 1995, Vol.22 (6), p.29-33

1995

Link zum Volltext

Verfügbarkeit prüfen

Apoptose radio-induite in vitro des lymphocytes circulants chez 25 patients atteints de leucémie lymphoïde chronique: variabilité individuelle et prédiction possible de l'efficacité de l'irradiation splénique à faible dose

Cancer radiothérapie, 1998-09, Vol.2 (5), p.550-551

1998

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of paclitaxel and epirubicin in patients with metastatic breast cancer : A preliminary report on safety: Paclitaxel (Taxol) : current practices and future directions in breast cancer management

Seminars in oncology, 1996, Vol.23 (1), p.24-27

1996

Link zum Volltext

Verfügbarkeit prüfen

354 Taxol® (paclitaxel) 225 MG/M2 by 3-hour infusion without G-CSF as a first line therapy in patients with metastatic breast cancer (MBC)

European journal of cancer (1990), 1995-11, Vol.31, p.S77

1995

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(41)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(22)
Female
(16)
Middle Aged
(14)
Adult
(12)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(12)
Male
(12)
Combined Modality Therapy
(11)
Life Sciences & Biomedicine
(11)
Oncology
(11)
Science & Technology
(11)
Aged
(10)
Biological And Medical Sciences
(10)
Lung Neoplasms - Drug Therapy
(10)
Medical Sciences
(10)
Lung Neoplasms - Radiotherapy
(8)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(7)
Chemotherapy
(7)
Radiotherapy Dosage
(7)
Survival Rate
(7)
Radiotherapy
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pericarditis and myocardial infarctions after Hodgkin's disease therapy

Results of a randomized clinical trial comparing two radiation schedules in the palliative treatment of brain metastases

Neoadjuvant combination of carboplatin and 5-FU in head and neck cancer: A randomized study

Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results

Neoadjuvant chemotherapy with carboplatin/5-fluorouracil in head and neck cancer

Phase I study of paclitaxel and epirubicin in patients with metastatic breast cancer: a preliminary report on safety

Local relapse and contralateral tumor rates in patients with breast cancer treated with conservative surgery and radiotherapy (institut gustave roussy 1970–1982)

Alternating radiotherapy and chemotherapy in 173 consecutive patients with limited small cell lung carcinoma

Alternating radiotherapy and chemotherapy schedules in limited small cell lung cancer: analysis of local chest recurrences

Optimisation de l'association radiothérapie et chimiothérapie dans les carcinomes bronchiques non à petites cellules

Risk of secondary acute leukemia and preleukemia after Hodgkin's disease: the Institut Gustave-Roussy experience

A phase II trial of radiochemotherapy with daily carboplatin, after induction chemotherapy (carboplatin and etoposide), in locally advanced nonsmall-cell lung cancer: Final analysis

Alternating radiotherapy and chemotherapy in limited disease small cell lung cancer

202 Phase I study of paclitaxel (P) over 1 hr infusion in combination with vinorelbine (V) in advanced non small cell lung cancer (NSCLC)

370 Taxol® (paclitaxel) and farmorubicin® (epirubicin) in metastatic breast cancer (MBC): Preliminary results of a phase I study

128 Preliminary results of a phase II study with Taxol ® (paclitaxel) and cisplatin in advanced non-small cell lung cancer (NSCLC)

352 Induction chemotherapy (ICT cisplatin and vinorelbine) followed by a combination of daily irradiation and carboplatine (CBDCA) in stage IIIB non small cell lung cancer (NSCLC): Final analysis of a phase II trial

Phase I studies of combined paclitaxel/epirubicin and paclitaxel/epirubicin/cyclophosphamide in patients with metastatic offast cancer: the French experience

2139 Chemotherapy followed by a combination of daily irradiation and carboplatine (CBDCA) in stage IIIB non small cell lung cancer (NSCLC): First interim analysis of a phase II trial

Local relapse and contralateral tumor rates in patients with breast cancer treated with conservative surgery and radiotherapy (Institut Gustave Roussy 1970-1982). IGR Breast Cancer Group

354 Efficacy of induction chemotherapy (ICT) before concomitant chemoradiotherapy (CRCT) is predictive of local control and survival in unresectable locally advanced non small cell lung cancer (NSCLC)

Phase I/II study of paclitaxel plus ciplatin as first-line chemotherapy for advanced non-small cell lung cancer : Preliminary results: Emerging strategies in medical oncology

Apoptose radio-induite in vitro des lymphocytes circulants chez 25 patients atteints de leucémie lymphoïde chronique: variabilité individuelle et prédiction possible de l'efficacité de l'irradiation splénique à faible dose

Phase I study of paclitaxel and epirubicin in patients with metastatic breast cancer : A preliminary report on safety: Paclitaxel (Taxol) : current practices and future directions in breast cancer management

354 Taxol® (paclitaxel) 225 MG/M2 by 3-hour infusion without G-CSF as a first line therapy in patients with metastatic breast cancer (MBC)

Suchergebnisse filtern